Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Consolidated Balance Sheets

v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 22,283 $ 29,653
Restricted cash 83
Restricted deposit 22 23
Trade receivables 10,160 9
Inventories 1,552 1,430
Other accounts receivable and prepaid expenses 758 543
Total current assets 34,858 31,658
Non-current assets:    
Restricted deposit 237 188
Operating lease right-of-use assets 3,327 2,711
Property and equipment, net 2,931 2,966
Intangible assets, net 216 245
Total non-current assets 6,711 6,110
Total assets 41,569 37,768
Current liabilities:    
Trade payables 763 1,133
Operating lease liabilities 598 529
Accrued liabilities and other 1,421 1,443
Total current liabilities 2,782 3,105
Non-current liabilities:    
Operating lease liabilities 2,748 2,382
Total non-current liabilities 2,748 2,382
Total liabilities 5,530 5,487
Commitments and contingencies
Shareholders’ Equity:    
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of June 30, 2023 (unaudited) and December 31, 2022; issued and outstanding: 11,405,394 and 11,186,481 ordinary shares as of June 30, 2023 (unaudited) and December 31, 2022, respectively 4,963 4,873
Additional paid in capital 119,720 118,099
Currency translation differences (969) (969)
Accumulated deficit (87,675) (89,722)
Total shareholders’ equity 36,039 32,281
Total liabilities and shareholders’ equity $ 41,569 $ 37,768